Infliximab in the treatment of extra‐intestinal manifestations of Crohn's disease

Abstract

Infliximab is an effective drug in the short-term treatment of EIMs complicating CD. Although relapse of EIMs occurs frequently, retreatment ensures effective control of the symptoms.